These findings highlight Mounjaros potential as an effective treatment for long-term weight management
Filed Under: Biologics, Dermatology, Immunology, Infectious Disease, Metabolic disease/endicrinology, Oncology Tagged With: AbbVie, biologic drugs, biosimilar competition, drug sales H1 2025, Eli Lilly, GLP-1 drugs, IL-23 inhibitors, immunology drugs, Keytruda patent expiry, loss of exclusivity, Merck, Novo Nordisk, obesity drugs, Oncology Therapeutics, patent cliff 2028, PD-1 inhibitors, pharmaceutical blockbusters, prescription drug market, Skyrizi, therapeutic categories Brian Buntz As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology
The number of sessions depends on the severity, age, and type of stretch marks
How does the Precision Peptide Genetic Test help with blood pressure management
Excess skin may also extend around the waist or hips, sometimes leading to skin irritation in folds or difficulty fitting comfortably into clothing